Lung Cancer News and Research

Latest Lung Cancer News and Research

Nonfunctional MED12 gene linked to chemotherapy resistance

Research published in Cell shows that people with tumors that have a nonfunctional version of the mediator 12 gene are resistant to drugs used to treat lung and colon cancer such as gefitinib.

26 Nov 2012

Interim GALAXY Phase 2b lung cancer study results to be presented at APLCC 2012

Synta Pharmaceuticals Corp. announced today that interim results of the Phase 2b portion of the GALAXY program will be presented on November 28, 2012 at 12:15 p.m. (JST) during the "Highlights of Oral Presentations" session at the Fifth Asia Pacific Lung Cancer Conference (APLCC 2012) in Fukuoka City, Japan.

26 Nov 2012

mRNA vaccines offer protection against influenza A virus infections in various animal models

CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, and the German Federal Research Institute for Animal Health, Friedrich-Loeffler-Institute (FLI), Germany, today announced that mRNA vaccines (RNActive) based on the company's RNA technology platform have the potential to provide effective protection against infectious diseases.

26 Nov 2012

Children with psoriasis at increased risk for obesity

Children with psoriasis have a greater risk for being overweight or obese than those without the disorder, report researchers.

23 Nov 2012

Smoking-related diabetes a modifiable risk factor

Cigarette smoking is a modifiable risk factor for impaired insulin secretion in Japanese men, show study findings.

23 Nov 2012

UPC teams conduct research in biomedical engineering to improve people's health

Systems to improve patient rehabilitation, methods that help detect diseases, and smart biomaterials for optimising treatments—scientific advances in the field of biomedical engineering are unstoppable. A number of leading UPC teams are carrying out research aimed at harnessing technology to improve people's health.

23 Nov 2012

Eating disorders common in adolescents attending emergency department

A significant percentage of adolescents attending hospital emergency response departments have eating disorders, suggest results from a US study.

22 Nov 2012

Computational apolipoprotein estimates ‘reliable’ for cardiovascular risk

Computational estimates of apolipoprotein B and apolipoprotein A1 can be used as reliable markers for atherosclerosis, report researchers.

22 Nov 2012

TGF-betaR inhibitors may counter drug resistance in cancer patients with MED12 mutations

Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene that determines resistance to a range of cancer drugs has been reported in a study published by Cell Press November 21st in the journal Cell.

22 Nov 2012

USPTO issues Notice of Allowance to Sanovas’ nested balloon catheter

Sanovas, Inc., a life science technology company focused on developing and commercializing the next-generation of micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the company's nested balloon catheter for localized drug delivery, a component of Sanovas' Vas Zeppelin Smart Catheter technology portfolio.

20 Nov 2012

Exercise counters negative bone effects of sedentariness in girls

Participation in weight-bearing exercise such as running or football significantly counteracts the effects of sedentary behaviors in adolescent girls, say researchers.

19 Nov 2012

Cancer Network, ONCOLOGY present two part primer report on targeted therapies in solid tumors

UBM Medica US announces that Cancer Network and the journal ONCOLOGY are presenting a two part primer report on targeted therapies in solid tumors.

17 Nov 2012

Transcription factor expression aids stage I lung cancer prognosis

Expression of thyroid transcription factor-1 is an independent predictor for recurrence of stage I lung adenocarcinoma and allows intermediate-grade tumors to be split into two prognostic subsets, scientists have found.

16 Nov 2012

Images of diseased organs have most impact on smokers

Labels that use graphic images as warnings on cigarette packaging have the most pronounced impact on adult smokers compared with other images or text-only labels, say researchers.

16 Nov 2012

Hearing impairment risk high with diabetes

People with diabetes are at high risk for developing a hearing impairment, report researchers.

16 Nov 2012

Denosumab associated with improved overall survival in NSCLC patients

It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.

16 Nov 2012

Patients expect too much of screening and prevention

Patients overestimate the benefit that can be expected from cancer screening and preventive medications, setting minimal acceptable benefits unrealistically high, the results of a New Zealand study indicate.

15 Nov 2012

Diabetic foot reconstruction with free flaps pays dividends

Diabetic foot reconstruction using free flaps has high success and survival rates, say researchers.

15 Nov 2012

Healthy ‘visual diet’ may help prevent eating disorders

A woman’s perception of her ideal body shape is strongly associated with the body mass index of women she sees in commonly viewed images such as those in magazines and on the television, show study findings.

15 Nov 2012

Simple ways to reduce risk of lung cancer

More than an estimated 160,000 people in the United States will die from lung cancer this year, making it the country's leading cause of cancer death. According to the National Cancer Institute, it surpassed breast cancer as the number one killer in women back in 1987. It causes more deaths than colon, breast and prostate cancer combined, according to the American Lung Association. Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.

15 Nov 2012